UTI Multi Cap Fund - Direct Plan - Growth Option

UTI Multi Cap Fund - Direct Plan - Growth Option sits in the middle of the pack for Multi Cap funds, currently carrying a 2-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 58/100.

Cost: At 0.81%, the expense ratio is meaningfully cheaper — about 11% below the Multi Cap category average of 0.91% (based on 111 comparable funds). Lower costs compound in your favour over long holding periods.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -0.05 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 13.02% is fairly typical for actively managed equity funds.

Who should invest: This fund is best suited to investors who want the fund manager to freely allocate across large, mid and small caps rather than being boxed into one segment. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.